baber/WOPTO huggingface dataset:
Patent AU-2005285878-B2 (AU)
Title: Cyclic amine derivative or salt thereof
Inventor: JUNYA OHMORI
IPC: C07C217/54
Filed: 2005-09-20
Granted: 2011-06-30
Abstract: A compound useful as an NMDA antagonist having a wide safety region which is a therapeutic agent for Alzheimer's disease, vascular dementia (vascular agnosia), Parkinson's disease, ischemic apoplexy, and pains or a preventive agent for these. The compound is an amine derivative or salt thereof characterized by comprising an amine-containing structure (A) and a di- or tricyclic fused ring (indane, tetralone, 4,5,6,7-tetrahydrobenzothiophene, 4,5,6,7-tetrahydrobenzofuran, 7,8-dihydro-6H-indeno[4,5-b]furan, 2,3-dihydro-1H-cyclopenta[a]naphthalene, etc.) bonded to the structure (A) through X (a bond, lower alkylene, etc.). The NMDA antagonist contains the derivative or salt as an active ingredient.
Patent AU-2005332661-B2 (AU)
Title: Polyester container with enhanced gas barrier and method
Inventor: SCHIAVONE ROBERT J
IPC: C08G63/82
Filed: 2005-11-15
Granted: 2011-04-21
Abstract: A polyester container with enhanced gas barrier properties includes a polyester composition having an IV of 0.65 dL/g to 1.0 dL/g and including a polyester and a reactive organic gas barrier enhancing additive. The polyester is made using at least one first polycondensation catalyst, non-limiting examples of which include metals in Groups 3, 4, 13, and 14 of the Periodic Table and includes a catalyst residue remaining in the polyester from formation of the polyester. The catalyst residue includes at least a portion of the at least one first polycondensation catalyst.
Patent AU-2006201506-B2 (AU)
Title: Gaming machine, game control method and game system
Inventor: OKADA KAZUO
IPC: G06F19/00
Filed: 2006-04-11
Granted: 2012-02-02
Abstract: In a gaming machine of the present invention, a processing device executes: a processing reading from a storage device 5 a program for shifting the game mode from a without-insurance mode to a with-insurance mode on condition that a specific number of game media have been inserted, and then executing the program; a processing reading from the storage device notification data for notifying that the game mode has been shifted to the 10 with-insurance mode, and outputting an image or sound to an output device basedupon the notification data; and a processing reading from the storage device a program for providing the player with a predetermined prof it when a predetermined variable, accumulatively counted every time a game is played after the 15 game mode has been shifted to the with-insurance mode, reaches a set value that is an object of comparison with the predetermined variable, and then executing the program. H:VsoniamYkeepYSPECIFICATIONSYP60493 English text AS837 (2).doc 11/04/06 Fig. 12 INSURANCE HELP MESSAGE When bonus game trigger "APPLE" does not appear during MAXBET of 600 games, insurance of 500 credits is paid out 0 ____60 Soo_ 0 o 40 500 20 150 O10 00 0 0 INSURANCE OFF 0 0 15L 150 15R 16 32--,-' PI BET ICREDIT/J- 3 What is INSURANCE? TOUCH TO BET
Patent AU-2006218874-B2 (AU)
Title: Aqueous disinfectants and sterilants
Inventor: TICHY DARYL J
IPC: A61K33/243
Filed: 2006-02-24
Granted: 2012-04-12
Abstract: The present invention is drawn to disinfectant or sterilant compositions, which are human safe, e.g., food grade or food safe. In one embodiment, an aqueous disinfectant or sterilant composition can comprise an aqueous vehicle, including water, from 0.001 wt% to 50 wt% of a peracid, and from 0.001 wt% to 25 wt% of a peroxide. Additionally, from 0.001 ppm to 50,000 ppm by weight of a transition metal based on the aqueous vehicle content can also be present. When the transition metal or alloy is present only in the form of an ionic metal or salt, the composition can be substantially free of aldehydes. Alternatively or additionally, the transition metal can be in the form of a colloidal transition metal and aldehydes may or may not be included.
Patent AU-2006226182-B2 (AU)
Title: Phosphoramidate derivatives of nucleoside compounds for use in the treatment of cancer
Inventor: COSTANTINO CONGIATU
IPC: A61P35/00
Filed: 2006-03-16
Granted: 2011-09-01
Abstract: Phosphoramidate derivatives of nucleoside compounds such as cladribine, isocladribine, fludaribine and clofarabine have enhanced therapeutic potency in homo sapiens, in particular, enhanced potency with respect to a cancer such as leukaemia. Suitably the phosphoramidate is substituted at the P atom by Ar-O, where Ar is aryl or heteroaryl, either of which may be optionally substituted. Formula (I).
Patent AU-2006231917-B2 (AU)
Title: Bicyclic [3.1.0] heteroaryl amides as type I glycine transport inhibitors
Inventor: LOWE III JOHN ADAMS
IPC: C07D413/12
Filed: 2006-03-27
Granted: 2011-07-28
Abstract: The present invention relates to a series of substituted bicyclic[3.1.0] heteroaryl amides of the Formula I, wherein A, Q, X, Y, Z and R-R groups are defined as in the specification, that exhibit activity as glycine transport inhibitors, their pharmaceutically acceptable salts, pharmaceutical compositions containing them, and their use for the enhancement of cognition and the treatment of the positive and negative symptoms of schizophrenia and other psychoses in mammals, including humans.
Patent AU-2006246039-B2 (AU)
Title: Polyethylene resin with narrow particle size distribution
Inventor: PRAET ERIK VAN
IPC: C08F297/08
Filed: 2006-04-27
Granted: 2009-12-17
Abstract: The present invention relates to a polyethylene resin comprising 
A) a first ethylene homo- or copolymer fraction, and 
B) a second ethylene homo- or copolymer fraction,  
wherein fraction (A) has a lower molecular weight than fraction (B), characterized in that the polymer resin powder obtained directly after the final polymerisation step has a particle size distribution PSD 95/5  equal to or smaller than 12.  Furthermore, the invention relates to a process for the production of a polymer composition comprising: 
(i) a step in which ethylene monomers, and optionally further alpha-olefin-comonomers, are polymerised in liquid phase in the presence of a polymerisation catalyst, 
(ii) a step in which ethylene monomers, and optionally further alpha-olefin comonomers, are polymerised in the gas phase in the presence of a polymerisation catalyst, and 
(iii) obtaining a polymer resin powder after the final polymerisation step wherein the powder has a particle size distribution PSD 95/5  equal to or smaller than 12.
Patent AU-2006272496-B2 (AU)
Title: Coumarin-based amino acids for use in enzyme activity and substrate specificity assays
Inventor: BARRIOS AMY M
IPC: G01N33/68
Filed: 2006-07-27
Granted: 2013-03-07
Abstract: The design, synthesis, and utilization of a novel coumarin-based amino acid and its fluorinated derivatives for use in enzyme activity and substrate specificity assays are described. The synthesis is both facile and high-yielding and allows for the production of a highly fluorescent phosphorylated amino acid that can be incorporated into peptides using standard SPPS techniques. The resultant substrates are efficiently hydrolyzed by PTPs and exhibit a large increase in fluorescence upon hydrolysis. Fluorinated CAP derivatives have utility as fluorogenic enzyme substrates. CAP and its derivatives can be incorporated into combinatorial peptide libraries for assaying enzyme substrate specificities.
Patent AU-2006301262-B2 (AU)
Title: Glide-angle light for approach guidance of aircraft
Inventor: LAENEN GUY
IPC: B64F1/20
Filed: 2006-10-09
Granted: 2011-05-26
Abstract: Disclosed is a glide-angle light for approach guidance of aircraft, comprising a housing with a light outlet opening in which a light channel with an optical axis is arranged, along which a light source for production of a light beam, a colored filter for splitting the light beam into a filtered beam component and an unfiltered beam component and a lens arrangement for focused emission of the light beam through the light outlet opening are arranged. Only a single light channel is arranged in the housing so that the glide-angle lights according to the invention can be produced at considerably less cost.
Patent AU-2007200832-B2 (AU)
Title: Hinge assembly
Inventor: BAKER RAYMOND
IPC: F21V21/14
Filed: 2007-02-26
Granted: 2012-11-29
Abstract: A hinge assembly including: a first hinge half and a second hinge half connected to the first hinge half for pivoting movement relative thereto between a closed position and an open position, the first hinge half and the second hinge half being adapted to be secured to separate upper and lower parts of a light pole respectively; first securing means for securing the first hinge half to the upper part and second securing means for securing the second hinge part to the lower part of the light pole; and locking means for selectively locking the hinge halves in the closed position. 37 -36 _ _3-2 - -14,16 17 21,' 2 23 ) 9 2 28 )21 3
Patent AU-2007201349-B2 (AU)
Title: Vacuum sewer system
Inventor: VESA LAPPALAINEN
IPC: E03F3/02
Filed: 2007-03-28
Granted: 2012-01-19
Abstract: The present invention relates to a sewer system comprising a sewage receptacle (1), sewer piping (3) connected to the sewage receptacle by means of a discharge valve (2), a vacuum generating means (4) for generating vacuum in the 5 sewer piping, and a control mechanism (5) for controlling the discharge valve. In order to achieve a more rapid closing of the discharge valve (2) after discharge of the sewage from the sewage receptacle (1), the vacuum sewer system further comprises an aeration means (10) in direct fluid communication with the discharge valve (2). The control mechanism (5) is arranged to control the aeration means (10). The 10 present invention also relates to a discharge valve (2) for such a vacuum sewer system. 28/03/07.16366 specification,2 LO)
Patent AU-2007209816-B2 (AU)
Title: Peelable composite thermoplastic sealants in packaging films
Inventor: ALBAUM GARY
IPC: B29C48/08
Filed: 2007-08-17
Granted: 2013-02-07
Abstract: A peelable sealing structure includes a sealing layer and one or more optional additional layers. The peelable sealing structure includes a sealing surface that is formable into a peelable seal upon contact with a sealing substrate 5 at all temperatures in a peelable seal temperature range. Moreover, the peelable sealing structure comprises a thermoplastic polymer and an additive dispersed within at least a portion of the thermoplastic polymer with the peelable sealing structure defining the sealing surface.
Patent AU-2007315213-B2 (AU)
Title: FGFR4 promotes cancer cell resistance in response to chemotherapeutic drugs
Inventor: BERGER HANS-JURGEN
IPC: C12Q1/68
Filed: 2007-11-02
Granted: 2013-06-13
Abstract: The present invention relates to Fibroblast-Growth Factor Receptor 4 (FGRF4) inhibitors for co-administration with a therapeutic procedure or/and agent for the prevention, alleviation or/and treatment of a hyperproliferative disorder, e.g. cancer, such as chemotherapy resistant cancer. Further, the present invention relates to a diagnostic procedure wherein expression status and/or polymorphisms of the FGFR4 gene are determined in a patient suffering from a hyperproliferative disorder, e.g. cancer. Based on the results of this determination and the status of the disorder to be treated a therapeutic protocol may be developed. Yet another subject of the present invention is a screening method.
Patent AU-2008210421-B2 (AU)
Title: Methods for determining cancer resistance to histone deacetylase inhibitors
Inventor: BALASUBRAMANIAN SRIRAM
IPC: A61K49/00
Filed: 2008-01-30
Granted: 2014-03-13
Abstract: [00153] Described herein are methods and compositions for determining whether a particular cancer is resistant to or susceptible to a histone deacetylase inhibitor or to histone deacetylase inhibitors. The methods include analysis of the expression levels of at least four biomarker genes associated with response to a histone deacetylase inhibitor. Also described herein are methods and compositions for increasing the likelihood of a therapeutically effective treatment in a patient, comprising an analysis of the expression levels of at least four biomarker genes associated with response to a histone deacetylase inhibitor. Also described herein are isolated populations of nucleic acids derived from a cancer sensitive to or resistant to a histone deacetylase inhibitor. Further described are kits and indications that are used in conjunction with the aforementioned methods and compositions.
Patent AU-2008229716-B2 (AU)
Title: A conformable wound dressing for use in apparatus for aspirating, irrigating and cleansing wounds
Inventor: MICHELLE WALKER TINA
IPC: A61M1/00
Filed: 2008-09-30
Granted: 2011-12-15
Abstract: Abstract A conformable wound dressing for use in an apparatus for aspiring, irrigating and/or cleansing wounds, said dressing comprising: a backing layer with a wound-facing face which is capable of forming a relatively fluid-tight seal or closure over a wound, the dressing has at least one inlet pipe for connection to a fluid supply tube, which passes through and/or under the wound-facing face, and at least one outlet pipe for connection to a fluid off-take tube, which passes through and/or under the wound facing face, the point at which the or each inlet pipe and the or each outlet pipe passes through and/or under the wound-facing face forming a relatively fluid-tight seal or closure over the wound, characterised in that the dressing comprises a wound filler. x 4 Section View on X-X FigE-
Patent AU-2008237535-B2 (AU)
Title: Facial Mask and Forehead Support
Inventor: GUNARATNAM MICHAEL KASSIPILLAI
IPC: A61M16/00
Filed: 2008-10-28
Granted: 2012-03-29
Abstract: FACIAL MASK AND FOREHEAD SUPPORT A forehead support (10) is disclosed that is adapted to be secured to, or form part of, a respiratory mask (16). The forehead support (10) includes a cushion frame (12) pivotally mounted to the joining member (14). The cushion frame (12) is adapted to locate one or more forehead cushions (25). The cushion frame (12) is also adapted to pivot relative to the joining member (14). A respiratory mask assembly comprising a respiratory mask (16) and a forehead support (10) adapted to be secured to the mask (16) is also disclosed.
Patent AU-2008245732-B2 (AU)
Title: High oil hybrid Brassica line 46P50
Inventor: THOONEN FERDINAND G
IPC: A01H6/20
Filed: 2008-04-24
Granted: 2014-03-13
Abstract: An improved Brassica hybrid plant and seed thereof designated 46P50 are provided. The Brassica hybrid produces seed having an average weight of oil per gram of mature dried seed that is between about 2.7 to 3.3 percentage points higher than that produced by current commercial hybrids when grown under the same environmental conditions. Also provided are methods for producing the hybrid plant, methods of oil and meal production, and methods of breeding with the hybrid plant.
Patent AU-2008256960-B2 (AU)
Title: Sweetener compositions having enhanced sweetness and improved temporal and/or flavor profiles
Inventor: SAN MIGUEL RAFAEL I
IPC: A23L27/30
Filed: 2008-05-16
Granted: 2014-06-05
Abstract: The present invention relates generally to improving the taste of sweetener compositions having enhanced sweetness. In particular, the present invention relates to compositions that can improve the tastes of sweetness enhanced sweetener compositions including at least one sweetness enhancer and at least one sweetener by imparting a more sugar-like taste or characteristic. In particular, the compositions and methods provide at least one sweetness enhancer, at least one sweetener comprising a carbohydrate sweetener, a natural-high-potency sweetener, a synthetic high-potency sweetener, or a combination thereof, and at least one sweet taste improving composition.
Patent AU-2008307000-B2 (AU)
Title: Proteome-wide quantification of small molecule binding to cellular target proteins
Inventor: GODL KLAUS
IPC: G01N33/543
Filed: 2008-09-26
Granted: 2014-08-28
Abstract: This invention relates to methods for the evaluation and/or quantification of the binding affinity of small molecules or other compounds to target components contained within an analyte, such as target proteins contained within the proteome of a cell or tissue.
Patent AU-2008345508-B2 (AU)
Title: Composition for treating sterile inflammation
Inventor: TALLBERG THOMAS
IPC: A61K33/24
Filed: 2008-12-17
Granted: 2013-11-14
Abstract: Biological medical means for treating sterile inflammatory diseases are disclosed. The invention relates to the use of L-arginine-hydrochloride (Arg) or lysine (Lys) and L- leucine (Leu) for the manufacture of a pharmaceutical composition for treating or preventing sterile inflammation. The composition further comprises trace elements chromium (Cr), tin (Sn), selenium (Se), strontium (Sr), vanadium (V), wolfram (W) and folic acid. The pharmaceutical composition can further comprise zinc (Zn) and or manganese (Mn) as well as central nervous system (CNS) lipids. Sterile inflammations are related to disorder such as fibromyalgia, Crohn's disease, psoriasis and rheuma.
Patent AU-2008365830-B2 (AU)
Title: Molten metal measuring system and probe used in the system
Inventor: AWAZU YOSHIYUKI
IPC: G01F23/26
Filed: 2008-12-22
Granted: 2012-05-31
Abstract: [PROBLEMS] This object is aimed to provide a system for stopping a probe while immersing the probe at a predetermined depth from the molten metal level, and the probe used in the system. [MEANS FOR SOLVING PROBLEMS] In a system, a sub-lance equipped with a probe is moved downward by a drive device controlled by a control device, the sub-lance is stopped while a portion to be immersed of the probe is immersed in molten metal, a measuring element of the molten metal is measured by a measuring means provided in the probe, and a slag sample is obtained by a molten slag obtaining means. A metal detection sensor (27) for detecting the level (ML) of the molten metal is provided in a portion to be immersed (23), and a stop position determining means (31) and a stop signal outputting means (32) are provided between the sensor (27) and a control device (18). When the level (ML) is detected by the metal detection sensor (27), the downward movement duration (Tx) of the sub-lance is determined by the stop position determining means (31), and when the upper end (U) of the portion to be immersed (23) reaches the level (ML), a stop signal is outputted from the stop signal outputting means (32).
Patent AU-2009200855-B2 (AU)
Title: Method and system for exploiting information from heterogeneous sources
Inventor: DURRANT-WHYTE HUGH
IPC: E21B44/00
Filed: 2009-03-04
Granted: 2014-05-15
Abstract: A system and method are described for generating a model of an environment in which a plurality of equipment units (104) are deployed for the extraction of at least one 5 resource from the environment. The system comprises a pre-extraction or in-ground modelling unit (204) configured to receive data from a first plurality of heterogeneous sensors in the environment and to fuse the data into a pre-extraction model descriptive of the environment and the at least one resource. An equipment modelling unit (208) is configured to receive equipment data relating to the plurality of equipment units 0 operating in the environment and to combine the equipment data into an equipment model. A post-extraction or out-of-ground modelling unit (206) is configured to receive data from a second plurality of sensors and to fuse the data into a post-extraction model descriptive of material extracted from the environment, wherein at least one of the equipment units operates to extract the at least one resource from the environment. 5 Information from at least one of the pre-extraction model, the equipment model and the post-extraction model is communicable to the equipment units for use in controlling operation of the equipment units in the environment. The environment may be a mine. (Figure 2) (N3 0 _ (0 0 E2f aw3 a)0 u 0 0 0) U)) 4-Ir E Q 0) U) 0) NN (NC (D W
Patent AU-2009227831-B2 (AU)
Title: Improvements in or in relation to pool cleaners
Inventor: KELLOGG JAMES EDWARD
IPC: E04H4/16
Filed: 2009-10-19
Granted: 2015-09-03
Abstract: A pool cleaner has a float and close proximity counterweight that together improve the applied torque to steer the pool cleaner, a body 13 has slots 33 diametrically opposed on the body 13 and these receive tangs 66 and 5 67 which depend from a circular body 68. The body 68 carries a circular guide-way 69 with a guide 70 travelling between opposite ends of the guide-way. Afloat 26 is connected to the guide by two pivot arms 71 and 72 which have openings at their ends so that they slide into position and are retained in place by snap in retainers 73 and 74. The guide 70 has a circular 10 shoulder 75 and at opposite ends of the guide has projections 76 and 77 such that the rail 78 of the guide-way is retained between the surface 75 and the inner surfaces 78 and 79 of the projections 76 and 77 with the rail against the surface 80. A corresponding structure is on the opposite side of the guide and this retains the rail 81 so that the guide slides around a circular path defined by 15 the rails 78 and 81. The guide 70 includes internal bores 82 and 83 at opposite ends and these are blind bores with an internal rib 84 so that stubs projecting from retainers 73 and 74 may snap fit into the bores 82 and 83 to retain the arms 71 and 72 in place and permit the pivoting action of the float 26 as illustrated in Figure 8 and Figure 9. S0" , I
Patent AU-2009244058-B2 (AU)
Title: Systems, assemblies, and methods for treating a bronchial tree
Inventor: MAYSE MARTIN L
IPC: A61B18/14
Filed: 2009-05-08
Granted: 2015-07-02
Abstract: Systems, assemblies, and methods to treat pulmonary diseases are used to decrease nervous system input to distal regions of the bronchial tree within the lungs. Treatment systems damage nerve tissue to temporarily or permanently decrease nervous system input. The treatment systems are capable of heating nerve tissue, cooling the nerve tissue, delivering a flowable substance that cause trauma to the nerve tissue, puncturing the nerve tissue, tearing the nerve tissue, cutting the nerve tissue, applying pressure to the nerve tissue, applying ultrasound to the nerve tissue, applying ionizing radiation to the nerve tissue, disrupting cell membranes of nerve tissue with electrical energy, or delivering long acting nerve blocking chemicals to the nerve tissue.
Patent AU-2009290585-B2 (AU)
Title: Demand side management module
Inventor: WATSON ERIC K
IPC: G05D5/00
Filed: 2009-09-15
Granted: 2016-01-07
Abstract: A household appliance system and method include an appliance control system having a common appliance interface provided on an appliance and a demand side management module connected to the common appliance interface. The module corresponds to one select utility of a plurality of utilities and is adapted to communicate with the one select utility of the plurality of utilities. The appliance control system operates the appliance based on communications with the one select utility through the module.
Patent AU-2009302340-B2 (AU)
Title: Sharps container
Inventor: ERICKSON THOMAS E
IPC: A61M5/00
Filed: 2009-10-08
Granted: 2015-02-12
Abstract: The disclosure relates to volumetrically efficient systems for distributing, storing, and dispensing a number of medical or laboratory sharps with subsequent safe disposal of the used sharps. The systems comprise first (20) and second (40) sharps containers configured such that the combined containers, as well as contained sharps, may be shipped in a volume approximately equivalent to the volume of one of the containers.
Patent AU-2009306592-B2 (AU)
Title: An antimicrobial composition
Inventor: CHAKRABORTTY AMIT
IPC: A01N31/06
Filed: 2009-10-08
Granted: 2013-05-23
Abstract: The present invention relates to an antimicrobial composition. It particularly relates to an antimicrobial composition for cleansing or personal care. It is an object of the present invention to provide antimicrobial compositions that have relatively fast antimicrobial action. Present inventors have surprisingly found that compositions comprising selected ingredients, namely thymol and terpineol, in selective proportions provide relatively quick antimicrobial action.